fluocinolone acetonide 0.1 MG/ML / hydroquinone 40 MG/ML / tretinoin 0.5 MG/ML Topical Cream [Tri-Luma]

RxCUI
1191264
RxNorm name
fluocinolone acetonide 0.1 MG/ML / hydroquinone 40 MG/ML / tretinoin 0.5 MG/ML Topical Cream [Tri-Luma]
Display name
TRI-LUMA (Topical)
Full name
fluocinolone acetonide 0.1 MG/ML / hydroquinone 40 MG/ML / tretinoin 0.5 MG/ML Topical Cream [Tri-Luma]
Term type
SBD
Status
Active
Strength
0.01-4-0.05%
Dose form
Cream
Route
Topical
Updated
2026-06-17 07:06:25

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
112011
Active start
112011
Multiple ingredient
YES
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
tretinoin0.5 MG / 1 MLtretinointretinoin
fluocinolone acetonide0.1 MG / 1 MLfluocinolonefluocinolone acetonide
hydroquinone40 MG / 1 MLhydroquinonehydroquinone

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Topical Cream316982

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
tretinoin10753
fluocinolone25126
hydroquinone5509

Source Vocabulary Codes#

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
0299-5950-020299-5950TRI-LUMA fluocinolone acetonide, hydroquinone, and tretinoinGalderma Laboratories, L.P.NDA021112
0299-5950-300299-5950TRI-LUMA fluocinolone acetonide, hydroquinone, and tretinoinGalderma Laboratories, L.P.NDA021112

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
NDA0211120299-5950TRI-LUMA fluocinolone acetonide, hydroquinone, and tretinoinNDAGalderma Laboratories, L.P.

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 8 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00299595002rxnav_ndcsyes
00299595030rxnav_ndcsyes
00299595003rxnav_historical_indirect
00299595005rxnav_historical_indirect
28105030030rxnav_historical_indirect
54868482000rxnav_historical
60433030103rxnav_historical
60433030130rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TRI-LUMAFLUOCINOLONE ACETONIDE, HYDROQUINONE, AND TRETINOINGalderma Laboratories, L.P.a35fa709-5eb5-4429-b38f-f1e0019bf0ee2024-10-24Warnings, Adverse reactionsExact identifier
ndc (package): 0299-5950-02
ndc (package): 0299-5950-30
ndc (product): 0299-5950
ndc11 (package): 00299595002
ndc11 (package): 00299595030
rxcui: 1191264

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a35fa709-5eb5-4429-b38f-f1e0019bf0eeTri-Luma 0.01 % / 4 % / 0.05 % Topical Cream [PSN] · fluocinolone acetonide 0.1 MG/ML / hydroquinone 40 MG/ML / tretinoin 0.5 MG/ML Topical Cream [Tri-Luma] [SBD] · Tri-Luma (fluocinolone acetonide 0.01 % / hydroquinone 4 % / tretinoin 0.05 % ) Topical Cream [SY]318These highlights do not include all the information needed to use TRI-LUMA Cream safely and effectively. See full prescribing information for TRI-LUMA Cream. TRI-LUMA ® (fluocinolone acetonide, hydroquinone, tretinoin) cream, 0.01%/4%/0.05% for topical use Initial U.S. Approval: 200220241024

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
a35fa709-5eb5-4429-b38f-f1e0019bf0eeThese highlights do not include all the information needed to use TRI-LUMA Cream safely and effectively. See full prescribing information for TRI-LUMA Cream. TRI-LUMA ® (fluocinolone acetonide, hydroquinone, tretinoin) cream, 0.01%/4%/0.05% for topical use Initial U.S. Approval: 2002Galderma Laboratories, L.P. | Hill Dermaceuticals, Inc. | G Production, Inc.20241024
6f9b70a7-c0fa-4d27-bd5b-9a48f9a6170bNational Council for Prescription Drug Programs20120724

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCC05AACorticosteroidsATC1-4fluocinolone acetonide
ATCS02BACorticosteroidsATC1-4fluocinolone acetonide
ATCS01BACorticosteroids, plainATC1-4fluocinolone acetonide
ATCD07ACCorticosteroids, potent (group III)ATC1-4fluocinolone acetonide
ATCD11AXOther dermatologicalsATC1-4hydroquinone
ATCL01XFRetinoids for cancer treatmentATC1-4tretinoin
ATCD10ADRetinoids for topical use in acneATC1-4tretinoin
FDASPLD012176RetinoidsCHEMhas_chemical_structuretretinoin
FDASPLN0000175576CorticosteroidEPChas_epcfluocinolone acetonide
FDASPLN0000175854Melanin Synthesis InhibitorEPChas_epchydroquinone
FDASPLN0000175607RetinoidEPChas_epctretinoin
FDASPLN0000175450Corticosteroid Hormone Receptor AgonistsMOAhas_moafluocinolone acetonide
FDASPLN0000175850Melanin Synthesis InhibitorsMOAhas_moahydroquinone
FDASPLN0000175851Depigmenting ActivityPEhas_pehydroquinone
MEDRTD005446Fluocinolone AcetonideCHEMhas_ingredientfluocinolone acetonide
MEDRTD005446Fluocinolone AcetonideCHEMhas_ingredientfluocinolone
MEDRTD006873HydroquinonesCHEMhas_ingredienthydroquinone
MEDRTD010226ParabensCHEMci_chemclasstretinoin
MEDRTD014212TretinoinCHEMhas_ingredienttretinoin
MEDRTD000152Acne VulgarisDISEASEmay_treattretinoin
MEDRTD003876Dermatitis, AtopicDISEASEmay_treatfluocinolone acetonide
MEDRTD003876Dermatitis, AtopicDISEASEmay_treatfluocinolone
MEDRTD004342Drug HypersensitivityDISEASEci_withtretinoin
MEDRTD004342Drug HypersensitivityDISEASEci_withhydroquinone
MEDRTD004342Drug HypersensitivityDISEASEci_withfluocinolone acetonide
MEDRTD004342Drug HypersensitivityDISEASEci_withfluocinolone
MEDRTD005148Facial DermatosesDISEASEmay_treattretinoin
MEDRTD005148Facial DermatosesDISEASEmay_treatfluocinolone acetonide
MEDRTD005148Facial DermatosesDISEASEmay_treatfluocinolone
MEDRTD005533Foot DermatosesDISEASEmay_treatfluocinolone
MEDRTD005533Foot DermatosesDISEASEmay_treatfluocinolone acetonide
MEDRTD006229Hand DermatosesDISEASEmay_treatfluocinolone
MEDRTD006229Hand DermatosesDISEASEmay_treatfluocinolone acetonide
MEDRTD017495HyperpigmentationDISEASEmay_treathydroquinone
MEDRTD017495HyperpigmentationDISEASEmay_treattretinoin
MEDRTD006967HypersensitivityDISEASEci_withfluocinolone acetonide
MEDRTD007249InflammationDISEASEmay_treatfluocinolone
MEDRTD007249InflammationDISEASEmay_treatfluocinolone acetonide
MEDRTD007868Leg DermatosesDISEASEmay_treatfluocinolone acetonide
MEDRTD007868Leg DermatosesDISEASEmay_treatfluocinolone
MEDRTD015473Leukemia, Promyelocytic, AcuteDISEASEmay_treattretinoin
MEDRTD011247PregnancyDISEASEci_withtretinoin
MEDRTD011537PruritusDISEASEmay_treatfluocinolone acetonide
MEDRTD011537PruritusDISEASEmay_treatfluocinolone
MEDRTD011565PsoriasisDISEASEmay_treatfluocinolone acetonide
MEDRTD011565PsoriasisDISEASEmay_treatfluocinolone
MEDRTD012536Scalp DermatosesDISEASEmay_treatfluocinolone acetonide
MEDRTD013471SunburnDISEASEci_withhydroquinone
MEDRTN0000000159Glucocorticoid Receptor AgonistsMOAhas_moafluocinolone acetonide
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moafluocinolone
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moafluocinolone acetonide
MEDRTN0000000085Receptor InteractionsMOAhas_moatretinoin
MEDRTN0000020001Tyrosine Kinase InhibitorsMOAhas_moahydroquinone
MEDRTN0000009915Unknown Cellular or Molecular InteractionMOAhas_moatretinoin
MEDRTN0000008297Antipruritic ActivityPEhas_pefluocinolone acetonide
MEDRTN0000175676Decreased Epithelial ProliferationPEhas_petretinoin
MEDRTN0000008663Decreased Immunologically Active Molecule ActivityPEhas_pefluocinolone acetonide
MEDRTN0000008663Decreased Immunologically Active Molecule ActivityPEhas_pefluocinolone
MEDRTN0000008841Decreased Protein SynthesisPEhas_pefluocinolone acetonide
MEDRTN0000008841Decreased Protein SynthesisPEhas_pefluocinolone
MEDRTN0000009982Decreased Sebaceous Gland ActivityPEhas_petretinoin
MEDRTN0000009979Decreased Sebaceous Gland QuantityPEhas_petretinoin
MEDRTN0000175851Depigmenting ActivityPEhas_pehydroquinone
MEDRTN0000009908VasoconstrictionPEhas_pefluocinolone acetonide
MEDRTN0000009908VasoconstrictionPEhas_pefluocinolone

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.1 MG/ML / 40 MG/ML / 0.5 MG/ML
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESNDANDA021112
NAMESPrescribable SynonymTri-Luma 0.01 % / 4 % / 0.05 % Topical Cream
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon